Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives

Overview

Journal Clin Endosc

Date 2016 Mar 10

PMID 26956193

Citations 126

Authors

Hyun Ho Choi

Young-Seok Cho

Affiliations

Soon will be listed here.

Abstract

Fecal microbiota transplantation (FMT) is the infusion of liquid filtrate feces from a healthy donor into the gut of a recipient to cure a specific disease. A fecal suspension can be administered by nasogastric or nasoduodenal tube, colonoscope, enema, or capsule. The high success rate and safety in the short term reported for recurrent Clostridium difficile infection has elevated FMT as an emerging treatment for a wide range of disorders, including Parkinson's disease, fibromyalgia, chronic fatigue syndrome, myoclonus dystopia, multiple sclerosis, obesity, insulin resistance, metabolic syndrome, and autism. There are many unanswered questions regarding FMT, including donor selection and screening, standardized protocols, long-term safety, and regulatory issues. This article reviews the efficacy and safety of FMT used in treating a variety of diseases, methodology, criteria for donor selection and screening, and various concerns regarding FMT.

Citing Articles

Gut Microbiome as Potential Therapeutics in Multiple Sclerosis.

Zhu W, Dykstra K, Zhang L, Xia Z Curr Treat Options Neurol. 2025; 23(11).

PMID: 39877812 PMC: 11774507. DOI: 10.1007/s11940-021-00693-1.

Influential articles in autism and gut microbiota: bibliometric profile and research trends.

Ying J, Zhang M, Wei K, Wong S, Subramaniam M Front Microbiol. 2025; 15():1401597.

PMID: 39850141 PMC: 11755156. DOI: 10.3389/fmicb.2024.1401597.

Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE mouse model of chronic apical periodontitis-induced atherosclerosis.

Gan G, Zhang R, Zeng Y, Lu B, Luo Y, Chen S BMC Oral Health. 2024; 24(1):1455.

PMID: 39614243 PMC: 11607875. DOI: 10.1186/s12903-024-05230-5.

The Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Various Neurocognitive Disorders.

Castro-Vidal Z, Mathew F, Ibrahim A, Shubhangi F, Cherian R, Choi H Cureus. 2024; 16(10):e72451.

PMID: 39600755 PMC: 11594437. DOI: 10.7759/cureus.72451.

Fecal microbiota transplantation alleviates cognitive impairment by improving gut microbiome composition and barrier function in male rats of traumatic brain injury following gas explosion.

Dong X, Su Y, Luo Z, Li C, Gao J, Han X Front Microbiol. 2024; 15:1485936.

PMID: 39552646 PMC: 11564976. DOI: 10.3389/fmicb.2024.1485936.

References

Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P . Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2014; 30(1):51-8. DOI: 10.1111/jgh.12727. View

Zhang F, Wang H, Wang M, Cui B, Fan Z, Ji G . Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease. World J Gastroenterol. 2013; 19(41):7213-6. PMC: 3819561. DOI: 10.3748/wjg.v19.i41.7213. View

Borgia G, Maraolo A, Foggia M, Buonomo A, Gentile I . Fecal microbiota transplantation for Clostridium difficile infection: back to the future. Expert Opin Biol Ther. 2015; 15(7):1001-14. DOI: 10.1517/14712598.2015.1045872. View

Hohmann E, Ananthakrishnan A, Deshpande V . Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea. N Engl J Med. 2014; 371(7):668-75. DOI: 10.1056/NEJMcpc1400842. View

Bennet J, Brinkman M . Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989; 1(8630):164. DOI: 10.1016/s0140-6736(89)91183-5. View

Borody T, Warren E, Leis S, Surace R, Ashman O . Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol. 2003; 37(1):42-7. DOI: 10.1097/00004836-200307000-00012. View

Patel N, Griesbach C, DiBaise J, Orenstein R . Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience. Mayo Clin Proc. 2013; 88(8):799-805. DOI: 10.1016/j.mayocp.2013.04.022. View

Satokari R, Mattila E, Kainulainen V, Arkkila P . Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection--an observational cohort study. Aliment Pharmacol Ther. 2014; 41(1):46-53. DOI: 10.1111/apt.13009. View

Surawicz C, Brandt L, Binion D, Ananthakrishnan A, Curry S, Gilligan P . Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108(4):478-98. DOI: 10.1038/ajg.2013.4. View

10.

Gweon T, Lee K, Kang D, Park S, Kim K, Seong H . A case of toxic megacolon caused by clostridium difficile infection and treated with fecal microbiota transplantation. Gut Liver. 2015; 9(2):247-50. PMC: 4351033. DOI: 10.5009/gnl14152. View

11.

Petrof E, Gloor G, Vanner S, Weese S, Carter D, Daigneault M . Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome. 2014; 1(1):3. PMC: 3869191. DOI: 10.1186/2049-2618-1-3. View

12.

Simren M, Barbara G, Flint H, Spiegel B, Spiller R, Vanner S . Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2012; 62(1):159-76. PMC: 3551212. DOI: 10.1136/gutjnl-2012-302167. View

13.

Gough E, Shaikh H, Manges A . Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011; 53(10):994-1002. DOI: 10.1093/cid/cir632. View

14.

Vrieze A, van Nood E, Holleman F, Salojarvi J, Kootte R, Bartelsman J . Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143(4):913-6.e7. DOI: 10.1053/j.gastro.2012.06.031. View

15.

Drekonja D, Reich J, Gezahegn S, Greer N, Shaukat A, MacDonald R . Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review. Ann Intern Med. 2015; 162(9):630-8. DOI: 10.7326/M14-2693. View

16.

Youngster I, Russell G, Pindar C, Ziv-Baran T, Sauk J, Hohmann E . Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014; 312(17):1772-8. DOI: 10.1001/jama.2014.13875. View

17.

Brandt L, Aroniadis O, Mellow M, Kanatzar A, Kelly C, Park T . Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012; 107(7):1079-87. DOI: 10.1038/ajg.2012.60. View

18.

Gordon H, Harbord M . A patient with severe Crohn's colitis responds to Faecal Microbiota Transplantation. J Crohns Colitis. 2013; 8(3):256-7. DOI: 10.1016/j.crohns.2013.10.007. View

19.

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

20.

Hamilton M, Weingarden A, Sadowsky M, Khoruts A . Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012; 107(5):761-7. DOI: 10.1038/ajg.2011.482. View